Product Image
Please see full prescribing and safety information, including boxed warning, for CARBOplatin vials.

Available in:

  • 450 mg per 45 mL multi-dose vials
  • 600 mg per 60 mL multi-dose vials


  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex

CARBOplatin Injection*

Brand Name Equivalent: PARAPLATIN (PARAPLATIN is a registered trademark of Bristol-Myers Squibb Company.)
Therapeutic Category: Antineoplastic Agent

PreventIV MeasuresTM Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Yellow and black cytotoxic warning flag designed to caution healthcare workers who handle the product
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
  • Tall Man lettering to help caregivers distinguish between drugs with similar names
Description Strength Fill
Concentration Container
Closure Unit
of Sale
202-45 Glass Vial 450 mg 45 mL 10 mg per mL 50 mL 20 mm 1 Vial
202-51 Glass Vial 600 mg 60 mL 10 mg per mL 100 mL 20 mm 1 Vial
Carboplatin Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Appropriate management of therapy and complications is possible only when adequate treatment facilities are readily available.
Bone marrow suppression is dose related and may be severe, resulting in infection and/or bleeding. Anemia may be cumulative and may require transfusion support. Vomiting is another frequent drug-related side effect.
Anaphylactic-like reactions to carboplatin have been reported and may occur within minutes of carboplatin administration. Epinephrine, corticosteroids, and antihistamines have been employed to alleviate symptoms.